subscribeSubscribe
Adial Pharma Announces Journal Publication Supporting AD04 For Alcohol Disorder

Adial Pharma Announces Journal Publication Supporting AD04 For Alcohol Disorder
GLOBENEWSWIRE
20 Jun 2024
Share Share
Health Canada Issues Recalls of Accel Pharma`s Ondansetron

Health Canada Issues Recalls of Accel Pharma`s Ondansetron

HEALTH CANADA
06 Jun 2024
Share Share
Enforcement Report - Week of December 13, 2023

Enforcement Report - Week of December 13, 2023
FDA
13 Dec 2023
Share Share
RedHill`s RHB-102 (BEKINDA®) & Opaganib Granted New Patents in Oncology Setting

RedHill`s RHB-102 (BEKINDA®) & Opaganib Granted New Patents in Oncology Setting
PR NEWSWIRE
01 May 2023
Share Share
Enforcement Report - Week of February 22, 2023

Enforcement Report - Week of February 22, 2023
FDA
22 Feb 2023
Share Share
Heron scores FDA for Aponvie, alternative to pills for postoperative nausea

Heron scores FDA for Aponvie, alternative to pills for postoperative nausea
Kevin Dunleavy FIERCEPHARMA
20 Sep 2022
Share Share
Athena’s First Market Authorization in Brazil with Ondansetron ODT

Athena’s First Market Authorization in Brazil with Ondansetron ODT
PRESS RELEASE
22 Mar 2022
Share Share
GlaxoSmithKline scores a big win in its Zofran litigation

GlaxoSmithKline scores a big win in its Zofran litigation
F. Kansteiner FIERCE PHARMA
03 Jun 2021
Share Share
Civica Rx & Hikma announce shipments of Heparin & 7 other injectable medicines

Civica Rx & Hikma announce shipments of Heparin & 7 other injectable medicines
PRESS RELEASE
10 Dec 2019
Share Share
Health Canada Issues Recall of CellChem Pharmaceuticals Ondansetron

Health Canada Issues Recall of CellChem Pharmaceuticals Ondansetron
HEALTH CANADA
16 Oct 2019
Share Share